Ultrapar Participacoes S A : Approval by the Administrative Tribunal of CADE of Extrafarma’s sale

ULTRAPAR PARTICIPAÇÕES S.A.

MARKET ANNOUNCEMENT

Approval by the Administrative Tribunal of CADE of Extrafarma's sale

São Paulo, June 22, 2022 - In addition to the material notice of May 18, 2021, and the market announcements of February 11, 2022, and May 9, 2022, Ultrapar Participações S.A. (B3: UGPA3; NYSE: UGP, "Ultrapar") hereby informs that the Administrative Tribunal of the Administrative Council of Economic Defense ("CADE") approved the sale of Extrafarma to Pague Menos S.A. ("Transaction"), through the execution of a Merger Control Agreement, providing for the divestment of 8 Extrafarma stores, which will not change the total enterprise value of the Transaction of R$ 700 million, which remains, however, subject to adjustments due mainly to changes in working capital and of Extrafarma's net debt position on the closing date of the transaction.

As provided for in the Merger Control Agreement, the closing of the Transaction was authorized by CADE due to the execution of a binding contract covering the sale of the aforementioned stores. Once the other conditions precedent set out in the sale agreement of Extrafarma are fulfilled, the parties will implement the closing of the Transaction, scheduled to take place on August 1, 2022.

Ultrapar will keep the market and its shareholders duly informed of any relevant updates related to this announcement.

Rodrigo de Almeida Pizzinatto

Chief Financial and Investor Relations Officer

Ultrapar Participações S.A.